| Mrs Margaret Banks Wilson, FNP-C | |
|
116 Defense Hwy Ste 400, Annapolis, MD 21401-7050 | |
| (410) 897-9841 | |
| (410) 897-9852 |
| Full Name | Mrs Margaret Banks Wilson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 116 Defense Hwy Ste 400, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538646880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | F07181617 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health, Inc | Towson, MD | Home health agency |
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Annapolis Internal Medicine, Llc | 2163324997 | 20 |
News Archive
As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.
U.S. District Judge Sam Sparks said in a ruling Monday that he cannot stop a new sonogram law from taking effect and pointedly suggested that three appellate court judges who overruled him last month had misapplied an earlier U.S. Court decision involving abortion. The state of Texas will begin enforcing the law Tuesday, according to a spokeswoman for the Texas Health Services Commission.
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
National Health Partners, Inc. (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced that it expects to generate positive cash flows from operating activities of almost $100,000 during August, representing the first time in the company's history that it has achieved positive cash flows from operating activities for a full month.
Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic version of Cymbalta® delayed-release (duloxetine hydrochloride) 20, 30 and 60 mg capsules.
› Verified 1 days ago
| Entity Name | Annapolis Internal Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477629681 PECOS PAC ID: 2163324997 Enrollment ID: O20040122000965 |
News Archive
As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.
U.S. District Judge Sam Sparks said in a ruling Monday that he cannot stop a new sonogram law from taking effect and pointedly suggested that three appellate court judges who overruled him last month had misapplied an earlier U.S. Court decision involving abortion. The state of Texas will begin enforcing the law Tuesday, according to a spokeswoman for the Texas Health Services Commission.
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
National Health Partners, Inc. (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced that it expects to generate positive cash flows from operating activities of almost $100,000 during August, representing the first time in the company's history that it has achieved positive cash flows from operating activities for a full month.
Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic version of Cymbalta® delayed-release (duloxetine hydrochloride) 20, 30 and 60 mg capsules.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Margaret Banks Wilson, FNP-C 116 Defense Hwy Ste 400, Annapolis, MD 21401-7050 Ph: (410) 897-9841 | Mrs Margaret Banks Wilson, FNP-C 116 Defense Hwy Ste 400, Annapolis, MD 21401-7050 Ph: (410) 897-9841 |
News Archive
As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.
U.S. District Judge Sam Sparks said in a ruling Monday that he cannot stop a new sonogram law from taking effect and pointedly suggested that three appellate court judges who overruled him last month had misapplied an earlier U.S. Court decision involving abortion. The state of Texas will begin enforcing the law Tuesday, according to a spokeswoman for the Texas Health Services Commission.
Regurin(R) XL (trospium chloride), a once-daily, prolonged-release capsule to treat patients with overactive bladder (OAB) has been launched in the UK. Regurin(R) XL provides rapid, significant and consistent improvements in the symptoms of OAB1 and has a reduced potential for central nervous system (CNS) side effects(2-7).
National Health Partners, Inc. (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced that it expects to generate positive cash flows from operating activities of almost $100,000 during August, representing the first time in the company's history that it has achieved positive cash flows from operating activities for a full month.
Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic version of Cymbalta® delayed-release (duloxetine hydrochloride) 20, 30 and 60 mg capsules.
› Verified 1 days ago
Brenda Kay Mathews-vitello, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 Defense Hwy, Suite 400, Annapolis, MD 21401 Phone: 410-897-9841 Fax: 410-897-9852 | |
Mrs. Jillian Lynn Preston, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 166 Defense Hwy Ste 101, Annapolis, MD 21401 Phone: 877-461-1564 | |
Alexa Lee St Laurent, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2024 West St Ste 400, Annapolis, MD 21401 Phone: 410-224-7667 Fax: 410-224-7007 | |
Dabney Lipscomb, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Wayson Pavilion, Suite 150, Annapolis, MD 21401 Phone: 443-481-1199 Fax: 443-481-1495 | |
Ms. Stephanie Zwonitzer, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1750 | |
Mrs. Hollis Stewart Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 678 Genessee St, Annapolis, MD 21401 Phone: 412-508-7896 | |
Lisa Kristine Butler, MSN, CRNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2002 Medical Pkwy Ste 670, Annapolis, MD 21401 Phone: 443-481-1150 |